Hong Kong
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 78.39 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
2 |
USD 32.95 M
|
June 30, 2024 | USD 1.12 | 0.90% |
|
Hong Kong |
|
3 |
USD 2.44 M
|
Dec. 31, 2023 | USD 2.09 | 16.76% |
|
Hong Kong |
|
4 |
USD 1.77 M
|
Dec. 31, 2023 | USD 0.50 | -0.05% |
|
Hong Kong |
|
5 |
USD -745.59 K
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
The Research & Consulting company in Hong Kong with the highest Gross Profit is Frontage Holdings Corporation (HKSE: 1521.HK) at USD 78.39 M.
The Research & Consulting company in Hong Kong with the lowest Gross Profit is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD -745.59 K.
The top 10 Research & Consulting companies in Hong Kong by Gross Profit are Frontage Holdings Corporation, CLPS Incorporation, WANG & LEE GROUP, Inc., CircuTech International Holdings Limited and Regencell Bioscience Holdings Limited.
The bottom 10 Research & Consulting companies in Hong Kong by Gross Profit are Regencell Bioscience Holdings Limited, CircuTech International Holdings Limited, WANG & LEE GROUP, Inc., CLPS Incorporation and Frontage Holdings Corporation.